These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10645206)

  • 1. Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectives.
    Van Cutsem E
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S1-2. PubMed ID: 10645206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
    Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
    Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C; Zucali P; Garassino I
    Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatments and future perspectives in colorectal and gastric cancer.
    Wilke HJ; Van Cutsem E
    Ann Oncol; 2003; 14 Suppl 2():ii49-55. PubMed ID: 12810459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raltitrexed: current clinical status and future directions.
    Van Cutsem E; Cunningham D; Maroun J; Cervantes A; Glimelius B
    Ann Oncol; 2002 Apr; 13(4):513-22. PubMed ID: 12056700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New oxaliplatin-based combinations in the treatment of colorectal cancer.
    Cassidy J; Hochster H
    Colorectal Dis; 2003 Nov; 5 Suppl 3():1-9. PubMed ID: 23573555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
    Cao S; Bhattacharya A; Durrani FA; Fakih M
    Expert Opin Pharmacother; 2006 Apr; 7(6):687-703. PubMed ID: 16556086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in systemic chemotherapy in advanced colorectal cancer.
    Cats A
    Scand J Gastroenterol Suppl; 2003; (239):78-86. PubMed ID: 14743888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.
    Caponigro F; Avallone A; Budillon A; Comella P; Comella G
    Anticancer Drugs; 2001 Jul; 12(6):489-97. PubMed ID: 11459994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen.
    Schüll B; Kornek GV; Schmid K; Raderer M; Ulrich-Pur H; Fiebiger W; Schneeweiss B; Lenauer A; Depisch D; Scheithauer W
    Onkologie; 2002 Aug; 25(4):358-62. PubMed ID: 12232488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
    Armand JP; Seymour L; Evans TR
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S14-8. PubMed ID: 10645209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies.
    Armand JP; Cunningham D; van Cutsem E; Misset JL; Kohne CH
    Anticancer Drugs; 1999 Nov; 10 Suppl 1():S5-12. PubMed ID: 10630362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer.
    Volk J; Reinke F; van Kuilenburg AB; van Gennip AH; Schlichting C; Ganser A; Schöffski P
    Ann Oncol; 2001 Apr; 12(4):569-71. PubMed ID: 11398894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin: a new therapeutic option in colorectal cancer.
    Cvitkovic E; Bekradda M
    Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study.
    Rosati G; Rossi A; Germano D; Reggiardo G; Manzione L
    Anticancer Res; 2003; 23(3C):2981-5. PubMed ID: 12926149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapeutic options in chemotherapy of advanced colorectal cancer].
    Reimer P; Rückle-Lanz H
    Med Klin (Munich); 2001 Oct; 96(10):593-8. PubMed ID: 11715331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.
    Scheithauer W; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger W; Gedlicka C; Schüll B; Brugger S; Schneeweiss B; Lang F; Lenauer A; Depisch D
    J Clin Oncol; 2002 Jan; 20(1):165-72. PubMed ID: 11773166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
    Feliu J; Castañón C; Salud A; Mel JR; Escudero P; Pelegrín A; López-Gómez L; Ruiz M; González E; Juárez F; Lizón J; Castro J; González-Barón M;
    Br J Cancer; 2005 Nov; 93(11):1230-5. PubMed ID: 16265344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in combination chemotherapy for colorectal cancer.
    Goetz MP; Grothey A
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):627-37. PubMed ID: 15270666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.